Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2024-09-20 00:00:00 ET · period of report 2024-09-18 · accession 0001415889-24-023779 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-20 | 2024-09-18+ | VERA | SEIDENBERG BETH C | Dir | S - Sale | $42.29 | -15.0K | 146.6K | -9% | -$634.3K |
| I | 2024-09-20 | 2024-09-18 | VERA | SEIDENBERG BETH C | Dir | S - Sale | $42.00 | -1,476 | 4,012 | -27% | -$62.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-09-18 | S | D | 1,177 | $42.01 | 160,376 | D | — | — | (F2) The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.07, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F4) On April 10, 2024, April 12, 2024, June 5, 2024 and June 13, 2024, the Reporting Person received an aggregate of 161,553 Shares as part of a pro-rata in-kind distribution without consideration from KPCB XVI, XVI Founders and their managing member, XVI Associates. The Reporting Person is one of the five managing members of XVI Associates. (F3) In prior reports, the Reporting Person reported indirect beneficial ownership of 1,949,295 shares of Class A Common Stock (the "Shares") held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and KPCB XVI Founders Fund, LLC ("XVI Founders"), whose managing member is KPCB XVI Associates, LLC ("XVI Associates"). On April 10, 2024, KPCB XVI and XVI Founders made a pro-rata in-kind distribution of 750,000 Shares without consideration to its members, including XVI Associates, and likewise on June 5, 2024, they made an additional pro-rata in-kind distribution of 1,199,295 Shares to its members, including XVI Associates. |
| 2 | Common | Class A Common Stock | 2024-09-19 | S | D | 13,823 | $42.31 | 146,553 | D | — | — | (F7) The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.79, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2024-09-18 | S | D | 1,476 | $42.00 | 4,012 | I See Footnote | — | — | (F5) On April 10, 2024 and June 5, 2024, an aggregate of 5,488 Shares were received as part of a pro-rata in-kind distribution without consideration from XVI Associates, the managing member of KPCB XVI and XVI Founders. The Reporting Person is one of the five managing members of XVI Associates. (F6) Shares are held by the Samuel B. Seidenberg Irrevocable Trust, established on July 1, 2013, for which the Reporting Person and her spouse serve as trustees. |